home
NCCR-SYNAPSY The Synaptic Bases of Mental Diseases
Researchers and psychiatrists of the Swiss National Centre Competence in Research NCCR-SYNAPSY have joined forces to study the biological basis of psychiatric disorders.
In order to offer patients new perspectives of a cure and a higher quality of life, this innovative union between psychiatry and neuroscience is seeking to better understand the origins of mental disorders, and thus settle upon better diagnosis and treatments.
SYNAPSY LATEST NEWS
Editorial by Camilla Bellone, Carmen Sandi and Philippe Conus
19 August 2020
Dear Colleagues, It is with a profound grief that we are writing the editorial of this issue of the NCCR...
Read More
Obsessive Compulsive Disorders: How to treat OCD?
7 September 2020
The fourth most common psychiatric illness, OCD affects between 2 and 3% of the population. Obsessive compulsive disorder, called OCD,...
Read More
Synapsy model imitated worldwide
19 August 2020
The translational graduate program at the International Max-Planck Research School for Translational Psychiatry – which is similar to Synapsy’s –...
Read More
Using genetics and sharing to study autism
19 August 2020
French researcher Thomas Bourgeron is a pioneer in genetic research on autism. The professor was also our guest at the...
Read More
What will the psychiatry of tomorrow look like?
19 August 2020
A female student in medicine at the University of Geneva (who is keen to remain anonymous) dreams of a career...
Read More
Confined planet: a challenge for women
14 July 2020
Following the WHO's announcement on the coronavirus pandemic, our planet entered several weeks of confinement. Since then, the scientific community...
Read More
Death of Prof. Alexandre Dayer, NCCR Synapsy director
30 June 2020
Dear members of the Synapsy community, It is with great sadness that I have to inform you of the tragic...
Read More
Gliapharm completes a CHF 2 Million financing to advance its drug development program
28 May 2020
GliaPharm SA has completed a CHF 2 million financing. The company is initially focusing on an orphan neurological disease caused...
Read More
Optimus Agora Prize for Carmen Sandi and Dominique de Quervain
22 May 2020
Dominique de Quervain and Carmen Sandi are being awarded Optimus Agora Prize. Their project “Stress” encourages interaction with the public....
Read More
